BATS BZX Real-Time Price
As of 9:56am ET
| +0.16 / +1.94%|
The 8 analysts offering 12-month price forecasts for ARIAD Pharmaceuticals Inc have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +12.83% increase from the last price of 8.42.
The current consensus among 8 polled investment analysts is to Buy stock in ARIAD Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.